← Eichor
Study identifier: NCT04295486 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

Condition: Venous Thromboembolism  ·  Sponsor: University of Miami

PhasePhase 2
Planned participants5478
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

This research study is attempting to answer the question of whether 81 mg aspirin once daily is as effective as 81 mg aspirin twice daily in preventing blood clots after total joint replacement surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Ramakanth Yakkanti, MD  ·  502-689-3127  ·  ramakanth.yakkanti@jhsmiami.org

Always discuss trial participation with your own doctor first.

Locations (1)

University of Miami HospitalMiami, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04295486